Literature DB >> 24177175

Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.

Joanna Watson1, Keith Shaw, Maria Macgregor, Steve Smith, Stephen Halloran, Julietta Patnick, Valerie Beral, Jane Green.   

Abstract

BACKGROUND: The NHS Bowel Cancer Screening Programme in England offers biennial screening to those aged 60-74 using a faecal occult blood test (FOBt) sent by post. Data from this national clinical programme can also be used for research. Awareness of the impact of such studies on screening participation is important. AIMS: To investigate the effect on screening uptake of adding a research questionnaire to the postal screening invitation.
METHODS: People invited for screening in 2008-10 in two areas of England were randomized to receive or not to receive an additional research study questionnaire, consent form and study information, either with their test kit or 2-3 days later. Uptake of screening was examined in relation to study mailings.
RESULTS: Among 11,579 people invited for screening by the Midlands and North West Bowel Cancer Screening Hub, screening uptake was significantly lower in those who received study documents with their FOBt kit than in those who did not (48.6% vs 53.5% respectively: p < 0.001). The reduction in uptake was similar in men and women, and was greater in people living in more deprived areas. Among a further 36,195 people invited for screening by the Midlands and North West and Southern Hubs, sending study documents by separate mailing 2-3 days after the FOBt kit did not affect screening uptake (uptake with and without additional study mailing: Midlands and North West, 56.7% and 56.2% respectively, p = 0.6; Southern, 52.0% and 51.4% respectively, p = 0.5).
CONCLUSIONS: Researchers planning studies that include contact with potential participants within the NHS Bowel Cancer and similar screening programmes should be aware of the potential impact on uptake.

Entities:  

Keywords:  cancer screening; colorectal neoplasms; questionnaires; utilization

Mesh:

Year:  2013        PMID: 24177175     DOI: 10.1177/0969141313511447

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  Precision Treatment and Prevention of Colorectal Cancer-Hope or Hype?

Authors:  Charles Muller; Matthew Yurgelun; Sonia S Kupfer
Journal:  Gastroenterology       Date:  2019-10-14       Impact factor: 22.682

2.  Self-Reported And Objectively Recorded Colorectal Cancer Screening Participation In England.

Authors:  Siu Hing Lo; Jo Waller; Charlotte Vrinten; Jane Wardle; Christian von Wagner
Journal:  J Med Screen       Date:  2015-09-25       Impact factor: 2.136

3.  Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model.

Authors:  Jennifer Anne Cooper; Nick Parsons; Chris Stinton; Christopher Mathews; Steve Smith; Stephen P Halloran; Sue Moss; Sian Taylor-Phillips
Journal:  Br J Cancer       Date:  2017-11-02       Impact factor: 7.640

4.  Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis.

Authors:  Belinda C Goodwin; Michael J Ireland; Sonja March; Larry Myers; Fiona Crawford-Williams; Suzanne K Chambers; Joanne F Aitken; Jeff Dunn
Journal:  Syst Rev       Date:  2019-11-04

5.  Rapid review of evaluation of interventions to improve participation in cancer screening services.

Authors:  Stephen W Duffy; Jonathan P Myles; Roberta Maroni; Abeera Mohammad
Journal:  J Med Screen       Date:  2016-10-17       Impact factor: 2.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.